Comparison of 2 approaches for determining the natural history risk of brain arteriovenous malformation rupture.
Estimating risk of intracranial hemorrhage (ICH) for patients with unruptured brain arteriovenous malformations (AVMs) in the natural course is essential for assessing risks and benefits of treatment. Traditionally, the survival period starts at the time of diagnosis and ends at ICH, but most patients are quickly censored because of treatment. Alternatively, a survival period from birth to first ICH, censoring at the date of diagnosis, has been proposed. The authors quantitatively compared these 2 timelines using survival analysis in 1,581 Northern California brain AVM patients (2000-2007). Time-shift analysis of the birth-to-diagnosis timeline and maximum pseudolikelihood identified the point at which the 2 survival curves overlapped; the 95% confidence interval was determined using bootstrapping. Annual ICH rates per 100 patient-years were similar for both the birth-to-diagnosis (1.27, 95% confidence interval (CI): 1.18, 1.36) and the diagnosis-to-ICH (1.17, 95% CI: 0.89, 1.53) timelines, despite differences in curve morphology. Shifting the birth-to-diagnosis timeline an optimal amount (10.3 years, 95% CI: 3.3, 17.4) resulted in similar ICH survival curves (P = 0.979). These results suggest that the unconventional birth-to-diagnosis approach can be used to analyze risk factors for natural history risk in unruptured brain AVM patients, providing greater statistical power. The data also suggest a biologic change around age 10 years influencing ICH rate.
Kim
Helen
H
Department of Anesthesia and Perioperative Care, School of Medicine, University of California, San Francisco, San Francisco, CA 94110, USA. kimhel@anesthesia.ucsf.edu
McCulloch
Charles E
CE
Johnston
S Claiborne
SC
Lawton
Michael T
MT
Sidney
Stephen
S
Young
William L
WL
D000328:Adult; D000367:Age Factors; D001164:Arteriovenous Fistula / Q000453:epidemiology / Q000209:etiology*; D002140:California / Q000453:epidemiology; D016009:Chi-Square Distribution; D016001:Confidence Intervals; D005260:Female; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D020300:Intracranial Hemorrhages / Q000453:epidemiology / Q000209:etiology*; D053208:Kaplan-Meier Estimate; D008297:Male; D016016:Proportional Hazards Models; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors
Crit Rev Neurosurg. 1999 May 25;9(3):141-146
10369967
Neurosurgery. 2008 Nov;63(5):823-9; discussion 829-31
19005371
Stroke. 2005 Oct;36(10):2099-104
16141419
Curr Opin Neurol. 2006 Feb;19(1):63-8
16415679
J Neurosurg. 2003 Jan;98(1):3-7
12546345
Acta Radiol. 1997 Jan;38(1):2-7
9059393
Stroke. 2004 Jul;35(7):1697-702
15166396
Am J Epidemiol. 1997 Jan 1;145(1):72-80
8982025
Neurosurgery. 2006 May;58(5):838-43; discussion 838-43
16639317
J Neurosurg. 2007 Mar;106(3):470-7
17367071
J Neurosurg. 1996 Nov;85(5):838-45
8893722
Stroke. 2007 Sep;38(9):2430-7
17673729
Stroke. 2006 Jan;37(1):231-4
16322490
Neurology. 2006 May 9;66(9):1350-5
16682666
J Neurosurg. 1996 Jul;85(1):14-8
8683264
No Shinkei Geka. 1991 Jan;19(1):75-8
2000161
Stat Med. 2004 Dec 30;23(24):3803-20
15580597
J Neurosurg. 1996 May;84(5):879-82
8622165
Stroke. 1996 Jan;27(1):1-6
8553382
Stroke. 2007 Dec;38(12):3308-9
17962585
No Shinkei Geka. 1988 Jun;16(7):887-91
3065672
Can J Neurol Sci. 1992 Feb;19(1):40-5
1562906
J Neurosurg. 2000 May;92(5):779-84
10794291
Childs Nerv Syst. 2007 Jan;23(1):31-7
17053936
J Neurosurg. 2007 Nov;107(5):965-72
17977268